Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 2451927, 18 pages
https://doi.org/10.1155/2017/2451927
Research Article

Effects of Aminoglycoside Antibiotics on Human Embryonic Stem Cell Viability during Differentiation In Vitro

1Department of Biochemistry, College of Medicine and Health Sciences, UAE University, Al Ain, Abu Dhabi, UAE
2Department of Anatomy, College of Medicine and Health Sciences, UAE University, Al Ain, Abu Dhabi, UAE

Correspondence should be addressed to Suraiya A. Ansari; ea.ca.ueau@irasnas

Received 6 April 2017; Revised 30 July 2017; Accepted 29 August 2017; Published 24 September 2017

Academic Editor: Heinrich Sauer

Copyright © 2017 Divya S. Varghese et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. B. Fischer, “Gentamicin as a bactericidal antibiotic in tissue culture,” Medical Microbiology and Immunology, vol. 161, no. 1, pp. 23–39, 1975. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Quiros, L. Vicente-Vicente, A. I. Morales, J. M. López-Novoa, and F. J. López-Hernández, “An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin,” Toxicological Sciences, vol. 119, no. 2, pp. 245–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. O. W. Guthrie, “Aminoglycoside induced ototoxicity,” Toxicology, vol. 249, no. 2-3, pp. 91–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Parker, W. H. Bennett, and G. A. Porter, “Animal models in the study of aminoglycoside nephrotoxicity,” in The Aminoglycosides: Microbiology, Clinical Use and Toxicology, A. Whelton and H. C. Neu, Eds., pp. 235–267, Marcel Dekker, Inc., New York, NY, USA, 1982. View at Google Scholar
  5. M. El Mouedden, G. Laurent, M. P. Mingeot-Leclercq, and P. M. Tulkens, “Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts,” Toxicological Sciences, vol. 56, no. 1, pp. 229–239, 2000. View at Publisher · View at Google Scholar
  6. G. M. Musiime, A. C. Seale, S. G. Moxon, and J. E. Lawn, “Risk of gentamicin toxicity in neonates treated for possible severe bacterial infection in low- and middle-income countries: systematic review,” Tropical Medicine & International Health, vol. 20, no. 12, pp. 1593–1606, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. C. P. Cross, S. Liao, Z. D. Urdang, P. Srikanth, A. C. Garinis, and P. S. Steyger, “Effect of sepsis and systemic inflammatory response syndrome on neonatal hearing screening outcomes following gentamicin exposure,” International Journal of Pediatric Otorhinolaryngology, vol. 79, no. 11, pp. 1915–1919, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Vazin and W. J. Freed, “Human embryonic stem cells: derivation, culture, and differentiation: a review,” Restorative Neurology and Neuroscience, vol. 28, no. 4, pp. 589–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Y. Moon, Y. B. Park, D. S. Kim, S. K. Oh, and D. W. Kim, “Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications,” Molecular Therapy, vol. 13, no. 1, pp. 5–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. N. Medine, B. Lucendo-Villarin, W. Zhou, C. C. West, and D. C. Hay, “Robust generation of hepatocyte-like cells from human embryonic stem cell populations,” Journal of Visualized Experiments, no. 56, article e2969, 2011. View at Publisher · View at Google Scholar
  11. S. M. Chambers, C. A. Fasano, E. P. Papapetrou, M. Tomishima, M. Sadelain, and L. Studer, “Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling,” Nature Biotechnology, vol. 27, no. 3, pp. 275–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. van de Leemput, N. C. Boles, T. R. Kiehl et al., “CORTECON: a temporal transcriptome analysis of in vitro human cerebral cortex development from human embryonic stem cells,” Neuron, vol. 83, no. 1, pp. 51–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Toivonen, K. Lundin, D. Balboa et al., “Activin A and Wnt-dependent specification of human definitive endoderm cells,” Experimental Cell Research, vol. 319, no. 17, pp. 2535–2544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. F. Grill and R. K. Maganti, “Neurotoxic effects associated with antibiotic use: management considerations,” British Journal of Clinical Pharmacology, vol. 72, pp. 381–393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. N. C. Boles, S. E. Hirsch, S. Le et al., “NPTX1 regulates neural lineage specification from human pluripotent stem cells,” Cell Reports, vol. 6, no. 4, pp. 724–736, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Basanta-Sanchez, S. Temple, S. A. Ansari, A. D'Amico, and P. F. Agris, “Attomole quantification and global profile of RNA modifications: epitranscriptome of human neural stem cells,” Nucleic Acids Research, vol. 44, no. 3, article e26, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Rubenstein, “Annual research review: development of the cerebral cortex: implications for neurodevelopmental disorders,” Journal of Child Psychology and Psychiatry, vol. 52, no. 4, pp. 339–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Baxter, C. Rowe, J. Alder et al., “Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening,” Stem Cell Research, vol. 5, no. 1, pp. 4–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Soto-Gutierrez, H. Basma, N. Navarro-Alvarez et al., “Differentiating stem cells into liver,” Biotechnology & Genetic Engineering Reviews, vol. 25, pp. 149–163, 2008. View at Publisher · View at Google Scholar
  20. M. Lelievre-Pegorier, R. Sakly, A. Meulemans, and C. Merlet-Benichou, “Kinetics of gentamicin in plasma of nonpregnant, pregnant, and fetal guinea pigs and its distribution in fetal tissues,” Antimicrobial Agents and Chemotherapy, vol. 28, no. 4, pp. 565–569, 1985. View at Publisher · View at Google Scholar
  21. U. Pirvola, L. Xing-Qun, J. Virkkala et al., “Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation,” The Journal of Neuroscience, vol. 20, pp. 43–50, 2000. View at Google Scholar
  22. K. Tabuchi, K. Pak, E. Chavez, and A. F. Ryan, “Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage,” Neuroscience, vol. 149, pp. 213–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. B. Coffin, E. W. Rubel, and D. W. Raible, “Bax, Bcl2, and p53 differentially regulate neomycin- and gentamicin-induced hair cell death in the zebrafish lateral line,” Journal of the Association for Research in Otolaryngology, vol. 14, pp. 645–659, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Q. Chen, K. Hill, Y. J. Guan, J. Schacht, and S. H. Sha, “Activation of apoptotic pathways in the absence of cell death in an inner-ear immortomouse cell line,” Hearing Research, vol. 284, pp. 33–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Y. Bae, L. S. Kim, D. Y. Hur, S. W. Jeong, and J. R. Kim, “Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas-Fas ligand signaling pathway,” The Laryngoscope, vol. 118, pp. 1659–1668, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Biro, H. Vaknine, M. Cohen-Armon et al., “The effect of poly (ADP-ribose) polymerase inhibition on aminoglycoside-induced acute tubular necrosis in rats,” Clinical Nephrology, vol. 85, pp. 226–234, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. A. H. Boulares, A. G. Yakovlev, V. Ivanova et al., “Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells,” The Journal of Biological Chemistry, vol. 274, pp. 22932–22940, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Chang, V. M. Goldberg, and A. I. Caplan, “Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells,” Clinical Orthopaedics and Related Research, vol. 452, pp. 242–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kagiwada, T. Fukuchi, H. Machida, K. Yamashita, and H. Ohgushi, “Effect of gentamicin on growth and differentiation of human mesenchymal stem cells,” Journal of Toxicologic Pathology, vol. 21, no. 1, pp. 61–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Llobet, J. Montoya, E. López-Gallardo, and E. Ruiz-Pesini, “Side effects of culture media antibiotics on cell differentiation,” Tissue Engineering Part C: Methods, vol. 21, no. 11, pp. 1143–1147, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Cohen, A. Samadikuchaksaraei, J. M. Polak, and A. E. Bishop, “Antibiotics reduce the growth rate and differentiation of embryonic stem cell cultures,” Tissue Engineering, vol. 12, pp. 2025–2030, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Hardy, “Apoptosis in the human embryo,” Reviews of Reproduction, vol. 4, no. 3, pp. 125–134, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. L. L. Alekseenko, V. I. Zemelko, V. V. Zenin et al., “Heat shock induces apoptosis in human embryonic stem cells but a premature senescence phenotype in their differentiated progeny,” Cell Cycle, vol. 11, no. 17, pp. 3260–3269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. P. J. Stambrook and E. D. Tichy, “Preservation of genomic integrity in mouse embryonic stem cells,” Advances in Experimental Medicine and Biology, vol. 695, pp. 59–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. K. J. Vinoth, B. C. Heng, A. Poonepalli et al., “Human embryonic stem cells may display higher resistance to genotoxic stress as compared to primary explanted somatic cells,” Stem Cells and Development, vol. 17, no. 3, pp. 599–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Saretzki, L. Armstrong, A. Leake, M. Lako, and T. von Zglinicki, “Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells,” Stem Cells, vol. 22, no. 6, pp. 962–971, 2004. View at Publisher · View at Google Scholar
  37. G. Saretzki, T. Walter, S. Atkinson et al., “Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells,” Stem Cells, vol. 26, no. 2, pp. 455–464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Armstrong, K. Tilgner, G. Saretzki et al., “Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells,” Stem Cells, vol. 28, no. 4, pp. 661–673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Lesniak, V. L. Pecoraro, and J. Schacht, “Ternary complexes of gentamicin with iron and lipid catalyze formation of reactive oxygen species,” Chemical Research in Toxicology, vol. 18, no. 2, pp. 357–364, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Karasawa and P. S. Steyger, “Intracellular mechanisms of aminoglycoside-induced cytotoxicity,” Integrative Biology (Camb), vol. 3, no. 9, pp. 879–886, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Prinsloo, M. M. Setati, V. M. Longshaw, and G. L. Blatch, “Chaperoning stem cells: a role for heat shock proteins in the modulation of stem cell self-renewal and differentiation?” BioEssays, vol. 31, no. 4, pp. 370–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. H. M. Beere, ““The stress of dying”: the role of heat shock proteins in the regulation of apoptosis,” Journal of Cell Science, vol. 117, Part 13, pp. 2641–2651, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. H. M. Beere, B. B. Wolf, K. Cain et al., “Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome,” Nature Cell Biology, vol. 2, no. 8, pp. 469–475, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Taleb, C. S. Brandon, F. S. Lee, M. I. Lomax, W. H. Dillmann, and L. L. Cunningham, “Hsp70 inhibits aminoglycoside-induced hair cell death and is necessary for the protective effect of heat shock,” Journal of the Association for Research in Otolaryngology, vol. 9, no. 3, pp. 277–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Karasawa, Q. Wang, L. L. David, and P. S. Steyger, “CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity,” Cell Death & Disease, vol. 1, article e102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Hashino and M. Shero, “Endocytosis of aminoglycoside antibiotics in sensory hair cells,” Brain Research, vol. 704, no. 1, pp. 135–140, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Nagai, H. Tanaka, N. Nakanishi, T. Murakami, and M. Takano, “Role of megalin in renal handling of aminoglycosides,” American Journal of Physiology - Renal Physiology, vol. 281, no. 2, pp. F337–F344, 2001. View at Google Scholar
  48. H. Servais, Y. Jossin, F. Van Bambeke, P. M. Tulkens, and M. P. Mingeot-Leclercq, “Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 4, pp. 1213–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Jiang, S. H. Sha, A. Forge, and J. Schacht, “Caspase-independent pathways of hair cell death induced by kanamycin in vivo,” Cell Death and Differentiation, vol. 13, pp. 20–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Manuvakhova, K. Keeling, and D. M. Bedwell, “Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system,” RNA, vol. 6, no. 7, pp. 1044–1055, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Schroeder, C. Waldsich, and H. Wank, “Modulation of RNA function by aminoglycoside antibiotics,” The EMBO Journal, vol. 19, pp. 1–9, 2000. View at Publisher · View at Google Scholar
  52. R. Manev and H. Manev, “Aminoglycoside antibiotics and autism: a speculative hypothesis,” BMC Psychiatry, vol. 1, p. 5, 2001. View at Publisher · View at Google Scholar · View at Scopus